- Walter S. Mossberg, who writes the Wall Street Journal's "Personal Technology" column, reviewed Apple's (NASDAQ: AAPL) new Leopard operating system, and said it was "better and faster than [Windows] Vista".
- Eli Lilly (NYSE: LLY) is halting two small studies of the most promising drug in its pipeline, prasugrel, which it hopes will bring over $1B a year in sales for the drug maker, reported the Wall Street Journal (subscription required).
- The Wall Street Journal reported that Microsoft Corporation (NASDAQ: MSFT) has beaten Google (NASDAQ: GOOG) in a closely watched contest, winning a minority stake in Facebook for $240M, and the right to sell advertising on the
Facebook site outside the U.S.. - JPMorgan Chase (NYSE: JPM) is considering acquiring a stake in a Chinese brokerage as part of its expansion strategy in the country, said Gaby Abdelnour, chairman and CEO of JPMorgan Asia Pacific, reported the Financial Times (subscription required).
- The Financial Times reported that Nintendo (OTC: NTDOY) raised its earnings outlook and announced that its 1H07 profits had tripled, thanks to the success of its Wii video game console and the DS, its handheld games player.
Last updated: May 16, 2012: 07:31 PM
Hot Stocks
DailyFinance Headlines
- Think Your Mortgage Refi Rate is Great? IBM Pays Less Than 1%
- Weird-Mart: Tales of the Bizarre from the Walmart Aisles
- Solid Reasons for the Unbanked to Shun Chase's New 'Liquid Card'
- GM Had 1,999 Reasons to Crash Facebook's IPO Party
- JCPenney's Ron Johnson: 'Customers Don't Get Our Pricing Strategy'
Benzinga Headlines
- Sears to Shed Clothing
- Is Cisco About to Buy NDS?
- Current Account, Import Prices Says US is Buying Goods on the Cheap
- Goldman Sachs Executive Director Calls the Bank "Toxic" on the Way Out
- BB&T Acquires BankAtlantic
TheFlyOnTheWall.com Headlines
- NetEase.com reports Q1 EPS $1.14, consensus $1.01
- U.S. FDA identifies violations of section 505(k) at Acorda Therapeutics
- Veolia Environment issues statement regarding sale of U.S. Solid Waste business
- iStar Financial announces new $20M stock repurchase plan
- Optimer announces positive results from DIFICID phase 3 studies
BioHealth Investor Headlines
- Shouldn’t VIVUS Raise Capital Now? (VVUS)
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
WalletPop Headlines
- Think Your Mortgage Refi Rate is Great? IBM Pays Less Than 1%
- Weird-Mart: Tales of the Bizarre from the Walmart Aisles
- Solid Reasons for the Unbanked to Shun Chase's New 'Liquid Card'
- GM Had 1,999 Reasons to Crash Facebook's IPO Party
- JCPenney's Ron Johnson: 'Customers Don't Get Our Pricing Strategy'
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
GM Kills $10 Million Facebook Ad Campaign Because It Didn't Work
JCPenney's Ron Johnson: 'Customers Don't Get Our Pricing Strategy'


